Clinical Trial Update: Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H) [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update assesses the safety of dose escalation in definitive hypofractionated radiation therapy with hormone therapy using SpaceOAR s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (Androgen deprivation therapy)
• SpaceOAR hydrogel spacer (SpaceOAR hydrogel spacer)

Snippet

Sponsor: Samsung Medical Center | Conditions: High Risk Prostate Carcinoma | Phase 2 | Status: RECRUITING